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We describe a new arachnophobia therapy that is specially suited for those individuals with severe arachnophobia who are reluc-
tant to undergo direct or even virtual exposure treatments. In this therapy, patients attend a computer presentation of images that,
while not being spiders, have a subset of the characteristics of spiders. The Atomium of Brussels is an example of such an image.
The treatment group (n = 13) exhibited a signiﬁcant improvement (time × group interaction: P = .0026) when compared to the
placebo group (n = 12) in a repeated measures multivariate ANOVA. A k-means clustering algorithm revealed that, after 4 weeks
of treatment, 42% of the patients moved from the arachnophobic to the nonarachnophobic cluster. Six months after concluding
the treatment, a follow-up study showed a substantial consolidation of the recovery process where 92% of the arachnophobic pa-
tients moved to the nonarachnophobic cluster.
Copyright © 2007 Laura Carmilo Granado et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
According to the DSM-IV manual (American Psychiatric As-
sociation [1]), speciﬁc phobias are anxiety disorders that are
characterized by an excessive, unreasonable, and persistent
fear that is manifested by the presence or expectation of an
object or feared situation (phobic situation). The manual
states that 9% of the population suﬀers from speciﬁc pho-
bias.
Spider phobia is one of the most common speciﬁc pho-
bias(Bourdonetal.[2]).Arachnophobicindividualsdevelop
an avoidance behavior for all contexts related to the animal
(APA [1]). Many patients are so afraid of being confronted
by the phobic object that they refuse to undergo any kind of
therapy (Marks [3]).
Existing therapies range from those that confront the pa-
tient with the real spider, such as “in vivo” exposure ther-
apy (Ost [4]), to those that avoid this confrontation by re-
quiring the patient to imagine situations involving spiders
(Hecker [5]). In between, several therapies try to minimize
the anxiety of the direct exposure by using computer simula-
tions in which either the patient himself (Garcia-Palacios et
al. [6, 7]) or a “virtual” person guided by the patient (Gilroy
et al. [8, 9]) interacts with a “virtual” spider.
The treatment proposed here (SLAT: spiderless arachno-
phobia therapy) does not use any spider, neither real nor vir-
tual or imaginary. It is speciﬁcally oriented to those patients
with severe arachnophobia that would not undergo any kind
oftherapyinvolvingaspider.Thistreatmentmakesuseofthe
idea that aversive information does not need to be perceived
consciously to trigger an emotional response. Nonconscious
processing mechanisms of emotionally relevant stimuli are
suﬃcient to activate the autonomic components of a pho-
bic reaction (¨ Ohman and Soares [10, 11]). From the neural
pointofview,fearfulinformationdoesnotneedtoreachcor-
tical levels to generate the typical fear response. Individuals
with bilateral destruction of the visual cortices exhibit amyg-
dala responses to emotional faces even when brain damage
is recent so that cortical networks have had too short time
to reorganize (Pegna et al. [12]). In this case, the amygdala2 Neural Plasticity
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Figure 1: Some “SLAT” images used in the treatment.
activationrequiresmediationbythalamic(pulvinarnucleus)
or tectal (superior colliculus) areas (Morris et al. [13]; Pegna
et al. [12]).
The thalamus and amygdala are, according to LeDoux et
al., responsible for recognizing fearful stimuli and trigger-
ing subsequent autonomic responses such as increased heart
rate, respiration, and sweating (LeDoux [14]; Doy´ ere et al.
[15]). According to these authors, when an aversive stimu-
lus arrives at the thalamus, it passes rough, almost archetypal
information, directly to the amygdala, producing a rapid re-
sponse to the possible danger.
The therapy proposed in this paper makes use of these
ideas by presenting to the patient a collection of images that
contain a reduced subset of the features of a spider. Figure 1
shows some of these images: the Atomium of Brussels in
which the spheres resembles the spider’s body, a carousel in
which the seats hang like the preys of a spider, a tripod whose
legs are articulated like spider’s legs, and so forth. These im-
ages, sharing a limited subset of features of a spider, were
called SLAT images. After a preliminary presentation, only
theimagesinwhichthefeaturesofthespiderappearinasub-
tler way are kept in the ﬁnal presentation. The images that
evoke spider-related feelings above a certain degree are dis-
carded from the ﬁnal therapeutic set (see Section 2.3.2). To
avoid the patient’s thoughts related to spiders while seeing
the treatment presentation, the patient is given a question
that should be answered at the end of the run, like “In how
many images there is a rounded object?”
2. METHODS
2.1. Participants
Patients were recruited by means of advertisements in sev-
eral newspapers and on television. Of the 160 volunteers that
made contact with us, 36 with symptoms of severe arachno-
phobia that were reluctant to undergo other types of treat-
ments were personally interviewed. They were then included
in the study if they (1) met DSM-IV criteria of speciﬁc pho-
bia (APA [1]) assessed by Structured Clinical Interview for
DSM-IV Axis I Disorders (SCID), (2) had been phobic for
at least ten years,1 (3) did not have any neurological or psy-
chiatric problems, and (4) were classiﬁed as arachnophobes
according to a k-means multivariate analysis.
1 We have arbitrarily chosen this duration as an additional criterion to re-
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Four volunteers were excluded because of the three ﬁrst
criteria.Afurther6wereexcludedbecausetheyhaddiﬃculty
in coming on a regular basis to the university to participate
in the experiments.
Regarding the last criterion, the k-means multivariate
analysis was conducted using as inputs the ﬁve measure-
ments obtained from a behavioral avoidance test (BAT) and
from the fear of spider questionaire (FSQ); see Section 3.
These instruments were applied to the remaining 26 volun-
teers, and to 29 nonphobic control subjects recruited among
the personnel and students of S˜ ao Paulo University, so that
the algorithm could establish two well-deﬁned clusters: the
arachnophobic and the nonarachnophobic cluster. After ap-
plying the k-means multivariate analysis, the 29 control sub-
jects were classiﬁed as nonphobic. One of the 26 volunteers
was characterized as nonphobic by the k-means analysis and
was eliminated from the study leaving 25 arachnophobic pa-
tients. The mean age and standard deviation of the arachno-
phobic patients and controls were 31.3 ± 7.4a n d3 2 .6 ± 8.2
years, respectively. The duration of phobia among the pa-
tients was 23.0 ± 8.6 years. The ﬁve measurements (see the
following section) that were used as inputs in the k-means
algorithm were (a) the distance tolerated to a real tarantula
in a BAT; (b) the distance tolerated to a photo of a tarantula
in a BAT; (c) the subjective percentage of anxiety according
to the subjective units of disconfort scale (SUDS), using a
real tarantula; (d) the percentage of anxiety with a photo of a
spider; (e) the numerical result of the FSQ test.
The chief advantage of the k-means algorithm is that it
usesamultivariateapproach(here,5measurements)inorder
to separate phobic from nonphobic subjects. This procedure
is more robust than adopting only one measurement, such as
the BAT or the result of the FSQ, as conventionally used for
separating phobic from nonphobic subjects. It is also impor-
tant to remark that the k-means algorithm does not use any
arbitrary parameter that can bias the results.
2.2. Spiderphobiaassessmenttechniques
To assess the degree of spider phobia, three diﬀerent instru-
ments were used. As described, the SCID (First et al. [16])
was used to produce a preliminary selection of participants.
Afterwards, the BAT and the FSQ provided the 5 measure-
ments used to evaluate if participants showed improvement.
2.2.1. StructuredClinicalInterviewforDSMIVAxisI
Disoders(SCID)
To verify that patients met DSM-IV criteria for speciﬁc pho-
bias (300.29), all of them underwent an SCID (First et al.
[16]).
2.2.2. Behavioralassessmenttest(BAT)
The BAT is a widely used measurement of clinical improve-
ment in speciﬁc phobias (Lang and Lazovick [17]; Lang et al.
[18]). It consists of an artiﬁcial situation in which the subject
approaches the phobic object until discomfort sets in. The
experimenter measures the distance from the subject to the
object and assesses the subject’s anxiety level using, in our
case, the SUDS scale (Wolpe [19]). These tests usually start
at 5 meters from the real spider, but in this study the initial
distance was established as 25 meters because of the severity
of arachnophobia in our patients.
The BAT was performed in two stages: ﬁrst with a photo
of a tarantula (Grammostola acteon, 20cm) and afterwards
with a real tarantula. In both cases the phobic object was
placed at the end of a 25-meter long corridor. Before begin-
ning the test, an assistant read the instructions to the subject:
“This is a behavioral assessment test and is not part of the
therapy. You are free to refuse my suggestions. Walk the far-
thest you are able to approximate to the spider at the end of
the corridor without forcing yourself. I will remain at this
point until you stop.” When the subject stops less than one
meter from the object, the assistant says: “Touch the photo”
or “Touch the cage” in the case of the real tarantula.
Note that instead of asking the patient to approach as
much as possible to the spider, the patient is asked to ap-
proach to the spider as much as possible without forcing
himself. This kind of suggestion guaranteed complying with
the desire of patients of not confronting in any way the pho-
bic object.
The BAT was rated by measuring the distance from the
subject to the phobic object, starting at 25 meters. The BAT
score ranged from 26 if the subject refused to do the test, to
−1, if the subject opened the lid of the cage. When subjects
stopped, the assistant applies the SUDS by saying: “Please,
rate you anxiety from 0% to 100%, 100% being the greatest
fear you have had in your life.”
2.2.3. Fearofspiderquestionnaire(FSQ)
The fear of spiders questionnaire (FSQ) assesses the subjec-
tive perception of spider fear (Szymanski and O’Donohue
[20]). It is composed of 18 questions rated on a 1–7 Likert
scale (1 = I strongly disagree, 7 = Is t r o n g l ya g r e e ) .T h eF S Q
was able to discriminate between phobics and nonphobics,
F(1.111)=5.99,P<. 01,F(1.76)=13.28,P<. 01,respectively
(Szymanski and O’Donohue [20]). It also provided evidence
for the improvement of phobic patients following a cogni-
tive restructuring treatment (comparing pretest to posttest:
t(37) = 4.38, P<. 01, t(79) = 5.09, P<. 01, resp.). When
applied to nontreated subjects, the instrument did not show
improvement from pretest to posttest. This instrument has
an internal consistency of 0.92 with a split half reliability of
0.89.
2.3. Presentationof“SLAT”ﬁgures
The presentation used in the SLAT consists of an initial set of
165 images, 124 of them having some features that resemble
any of the characteristics (color, shape, texture, etc.) of a spi-
der and were selected as explained in Section 2.3.1. Examples
include the image of a person with a Rastafarian hair style,
the Atomium of Brussels, a carousel, and so forth.4 Neural Plasticity
The remaining 41 images were neutral and were selected
with the purpose of making it more diﬃcult for the subject
to realize there were SLAT images in the presentation.
The placebo group presentation consisted of a sequence
of images without arachniform features. Among the selected
ﬁgures, there were abstract or surreal paintings that might
induce placebo subjects to think there was something hidden
in the ﬁgures.
2.3.1. Selectionofﬁgures
The images were selected from the Internet. We chose 132
images with spider features and 44 neutral images. The fea-
tures that were selected in the images were related, for ex-
ample, to the radial symmetry of spiders, the design of their
webs, their texture, the way they articulate their legs, the
hook-likeshapeoftheirextremities,orthefactthattheyhang
from a string.
For validating our selection, 43 nonarachnophobic per-
sons were asked to rate, on a 0 to 10 scale, the content of
spider features in all the images. Not to bias the process of
rating the images, no instructions related to what features to
consider in rating the images were given to these persons.
It was necessary to establish a threshold in this scale for
separating SLAT images from neutral images. This threshold
wasobtainedbymeansoftheBayesdecisionrulethatyieldsa
threshold of0.92. Imageswitha greaterrate wereclassiﬁedas
SLAT images, and images with a lower rate were classiﬁed as
neutral. According to this rule, 8 of the ﬁgures initially classi-
ﬁ e da sS L A Ti m a g e sw e r en e u t r a l ,a n d3n e u t r a lﬁ g u r e sw e r e
SLAT images. Therefore, a total of 11 images were excluded
from the ﬁnal therapeutic repertoire. To apply the Bayes de-
cision rule, a histogram was created giving the probability of
ﬁndingaSLATimageinsideintervalsof0.6unitlengthinthe
0 to 10 “arachniform scale.” The same was done with neu-
tral images. We replaced both histograms by two curves after
smoothing the histograms by using interpolation by splines.
The intersection of the two curves yielded the value of 0.92
that served to discriminate between SLAT and neutral im-
ages.
2.3.2. Adjustmentofpresentationintervals
OneoftheassumptionsthatservedtodelineatetheSLAT(see
assumption (a) in Section 4.1) deals with avoiding a high ac-
tivationintheneuralcircuitsinvolvedinfear.Forthisreason,
we elaborated a procedure to exclude from the ﬁnal ther-
apeutic presentation those images that might produce dis-
comfort in the patients, keeping only the more comfortable
images that would probably not produce a high degree of ac-
tivation in these neural circuits.
We adopted the following procedure.
(a) Once the entire set of ﬁgures had been shown to the
patient in a preparatory presentation, we asked the patient to
see the ﬁgures once more and collaborate with us to deter-
mine the adjusted duration, Tad, of each one of the images.
The patient was instructed as follows: “Each one of the fol-
lowing images will be presented by default for 5 seconds. If
you do not like the image, press the “Enter” button to pass to
thefollowingimagesooner.Thesooneryoupressthebutton,
the more fearful we will understand the image to be for you.”
(b) After seeing all images the subjects were asked:
(1) Which images, if any, are intolerable?
(2) Which images are tolerable?
(3) Which images are so nice that you might place them in
your bedroom?
With all this information, nine rules were applied to ob-
taintheﬁnaldurationofeachimage,Tad,inthepresentation.
As some patients were faster than others in pressing the “En-
ter” button, the average time Tm for each subject served as
the patient’s unit of time.
In the following rules, times T0, T1, and so on were set
as arbitrary multiples of Tm. The adjusted duration of each
image, Tad, was obtained by multiplying the duration chosen
by the subject in the preparatory presentation, T,b yac o e ﬃ-
cient calculated as follows.
We deﬁned three thresholds: T0 = Tm/5, T1 = Tm/2,
T2 = Tm/3.
(1) If T<T 0, the image was eliminated from the presen-
tation.
(2) Intolerable images with T<T 1 were also eliminated.
(3) Tad = 0.2∗T in intolerable images with T>T 1.
(4) Tad = T for tolerable images with T<T 2.
(5) Tad = 1.5∗T for tolerable images with T1 >T>T 2.
(6) Tad = 1.8∗T for tolerable images with T>T 1.
(7) Tad = 2∗T in images deemed nice.
(8) Other images, not included in previous groups, main-
tained their time T.
(9) To make the total presentation time equal to 12 min-
utes, each Tad was multiplied by 12 and divided by the
total duration (in minutes) of the presentation.
All procedures were the same for the placebo group.
2.4. Procedure
This research was approved by the Ethics Committee on Re-
search of the Institute of Psychology of the University S˜ ao
Paulo.
AsmentionedinSection 2.1,ofthe160patientsthatcon-
tacted us, 36 were interviewed and 25 were included in the
experiment. These patients signed forms, agreeing to partic-
ipate in either the placebo or treatment group, and allow the
use of collected data for research. Patients were randomly
divided into two groups: treatment (n = 13) and placebo
(n = 12).
After adjusting the timing of the presentation, a person-
alized CD was prepared for each patient. In the following
session, this CD was given to the patient. The patient was
then instructed to run the presentation twice a day at home
preferably during moments in which she/he was not tired or
under stress. Prior to each presentation run, the patient was
given one question to answer at the end of the run. These
questions were intended to distract the patient from arachni-
formfeaturesintheimages.Examplesinclude:“Inhowmany
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is a rounded object?” When answering the question, the pa-
tient was instructed to write, beside the answer, the date and
time she/he ran the presentation. Every week these data were
checked out in order to verify the rate of cooperation of pa-
tients and to encourage noncooperative patients, if any. In
all subjects, the cooperation was satisfactory and no statistics
were deemed necessary to measure the rate of cooperation.
To assess progress during the treatment, placebo and
treatment subjects underwent the BAT (including the SUDS)
each week. In the last week, the FSQ was also applied. Ex-
periments were carried out in three stages. In stage 1, data
collected during these ﬁrst four weeks were used to compare
placeboandtreatmentgroups.Aperiodoffourweekswases-
tablished prior to the experiment with the intention of mini-
mizing the duration of the experiment in order to avoid drop
out.Instage2,thetreatmentgroup(butnottheplacebo)was
a s k e d( a n dl u c k i l ya gr e e d )t oc o n t i n u ef o rt w om o r ew e e k st o
assess if this additional time might help the treated group to
achieve a more substantial recovery. They were evaluated at
the end of the 6th week.
Instage3,afterthefourthweek,placebosubjectswerein-
vited to receive the SLAT. The ten subjects that were accepted
were treated for 6 weeks and evaluated after the 4th and 6th
weeks.
3. RESULTS
3.1. Comparisonbetweenplaceboandcontrol
groupsatthebeginningofthestudy
There were no diﬀerence between the placebo (n = 12) and
treatment (n = 13) groups at the beginning of the study
in the following demographic and clinical variables: age,
F(1,23) = 0.3315, P = 0.5703; duration of phobia, F(1,23)
= 3.8758, P = .0611. No signiﬁcant diﬀerences were found in
behavioral variables during the initial BAT test with the real
spider BAT: F(1,23) = 0.0015, P = .9692; SUDS, F(1,23) =
0.0739, P = .7881; or with the spider photo BAT, F(1,23) =
1.6764, P = .2082; SUDS, F(1,23) = 0.0003, P = .9866. No
signiﬁcant diﬀerence was found in the subjective measure of
fear of spiders, FSQ: F(1,23) =0.020, P = .8895.
Of the 13 treatment subjects, 3 refused to stay at any
distance from the real spider if the spider was visible. They
received an arbitrary score of 26, one meter more than the
maximum score of 25 meters used in the BAT test. Regarding
the test with the spider photo, one subject refused to stay at
any distance in which he could see the photo. Analogously,
we assigned a score of 26 meters in the BAT test to this sub-
ject. We emphasize that, diﬀerent from previous studies in
which the initial distance of the BAT test was standardized to
5 meters, this distance was augmented to 25 meters because
of the desire of the patients not to confront the spider in any-
way.
3.2. Comparativeevolutionofplaceboand
treatedgroups
Table 1 shows the mean and standard deviation (in paren-
thesis) of the various groups evaluated. The percentage im-
provement (Table 2) was calculated by dividing the absolute
improvement in each measure by the initial measure. After 4
weeks, the percentage improvement in all measurements was
higher in the treated than in the placebo group. During the
presentation of the real spider, the percentage improvement
intheBATwasmorethantwiceashigh(61.6%versus28.8%)
in the treated than in the placebo group (see Table 2). The
SUDS was more than six-fold (40.3% versus 5.9%) higher.
The same measurements made with the spider photo yielded
a percentage improvement of 19.3% (66.6%–47.3%) in the
BAT and 32% (53%–21%) in the SUDS. Diﬀerences between
placebo and treated groups were consistent throughout the
four weeks of the experimental procedure (see evolution of
measures in Figure 2).
Improvement in the FSQ was 13.1% (28.8%–15.7%)
higher in the treatment than in the placebo group.
3.2.1. RepeatedmeasuresmultivariateANOVA
A2( g r o u p )×5 (times) repeated measure multivariate
ANOVA (Hair et al. [21]) was conducted to evaluate whether
the diﬀerences between placebo and treated groups were sig-
niﬁcant. In this multivariate analysis, 4 simultaneous vari-
ables were used: BAT and SUDS for real spiders; and BAT
and SUDS for spider photo. By analyzing the results of the
multivariate ANOVA, we conclude that the signiﬁcant time
eﬀect F(4,92) = 14.5475, P<. 0001, and the signiﬁcant group
eﬀect F(1,23) = 4.5678, P = .04344 show the eﬀectiveness of
the treatment. The signiﬁcantly diﬀerent time-course of the
improvement in the two groups is also reﬂected in a signif-
icant group × time eﬀect F(4,92) = 4.4217, P = .0026. In
order to evaluate how the test with the real spider and the
test with the spider photo contribute to these results, a 2-
group, ×5t i m e s ,m u l t i v a r i a t eA N O V Aw a sp e r f o r m e d ,ﬁ r s t
with the BAT and SUDS of the real spider and then with the
BAT and SUDS of the spider photo. The test with the real
spider yielded a signiﬁcant group × time interaction: F(1,23)
= 7.981610, P = .009598, MS = 1369.772 while the test with
the spider photo yielded a moderate group × time interac-
tion F(1,23) = 2.908077, P = .101608, MS = 750.1708. The
FSQ also yielded a nonsigniﬁcant 2 (groups) ×2( t i m e= pre-
treatmentversusposttreatment)interactionF(1,23) =1.833,
P = .188. The diﬀerence between BAT and SUDS tests and
the FSQ test results are analyzed in the discussion.
3.3. Resultsofprolongingtreatmentuntil
thesixthweek
After the four weeks in which placebo and treated sub-
jectswerecompared,treatedsubjectscontinuedreceivingthe
SLAT for two more weeks, achieving 76.6% improvement in
theBATand45.6%intheSUDSwiththerealspider.Withthe
spider photo, there was an 88.5% improvement in the BAT; a
61.4% improvement in the SUDS, and a 40% improvement
in the FSQ.
The results of the treated placebo were consistent with
the results of the treatment group (see Tables 1 and 2).6 Neural Plasticity
Table 1: Means and standard deviations (in parenthesis)of the BAT,SUDS, and FSQscores. Treatment (n = 13)and placebo (n = 12) group
scores were gathered and compared at the end of the 4th week. Treatment group continued treatment until the 6th week. After 4 weeks, ten
placebo subjects also underwent treatment, and their improvement was calculated at the 4th and 6th weeks of treatment. Six months later, a
follow-up study was performed.
Real spider Spider photo FSQ
BAT SUD BAT SUD
Treatment
Start 15.6 (7,7) 82.8 (17,9) 12.3 (8.6) 56.9 (24.3) 105.5 (11.2)
4 weeks 5.9 (4.4) 50 (22.4) 3.2 (2.7) 22.3 (17) 74.7 (23.2)
6 weeks 3.9 (5.4) 43.5 (32.5) 1.4 (2) 17.7 (19.3) 63 (30.2)
6 months (follow-up) 2.01 (3.9) 32.1 (27.5) 1.0 (1.53) 14.6 (19.1) 48.2 (27.0)
Placebo
Start 15.7 (7.2) 80.8 (19.2) 8.7 (4.8) 57.1 (22.8) 107.7 (16.8)
4 weeks 10 (5.2) 73.8 (25.9) 4 (3.7) 44.2 (28.7) 90.8 (22.7)
Treatedplacebo
Start 10.8 (5.3) 81 (20.9) 4.6 (3.6) 49 (28.8) 99.1 (15.5)
4 weeks 5.9 (5.2) 60.5 (26.5) 2.1 (2.5) 27.9 (31) 73.4 (23.1)
6 weeks 3.1 (4.9) 45.6 (33.9) 1.1 (1.7) 23.2 (29.2) 59.6 (26.4)
6 months (follow-up) 1.8 (3.00) 34.2 (27.2) 0.6 (1.1) 19.9 (21.0) 49.2 (28.4)
Treatmentandtreatedplacebo
Start 13.5 (7.0) 82.0 (18.8) 9.0 (7.8) 53.5 (26.0) 102.7 (13.3)
4 weeks 5.9 (4.6) 54.6 (24.3) 2.8 (2.6) 24.7 (23.6) 74.1 (22.6)
6 weeks 3.6 (5.1) 44.4 (32.4) 1.3 (1.7) 20.1 (23.7) 61.5 (28.0)
6 months (follow-up) 1.91 (3.4) 33.1 (26.7) 0.8 (1.3) 17 (19.2) 48.6 (26.9)
3.4. Six-monthfollow-upstudy
A six-month follow-up study was also performed. It showed
a substantial consolidation of previously obtained results.
There was 90.2% improvement in the treatment group in the
BAT test: patients were capable of approaching a live taran-
tula at 2(3.9) meters (on average), six patients opened the lid
of the tarantula cage and, of these, three patients touched the
tarantula (Grammostola acteon, 14cm, the initial one died).
In the case of the follow-up study with the treated
placebo patients, there was an improvement of 79.2% in the
BAT test. Three of them opened the lid of the cage and two
of them touched the tarantula.
Only one patient dropped out of the follow-up study.
3.5. k-meansclusteranalysis
Ak-meansmultivariateclusteranalysiswasusedtoassessthe
number of patients that made the transition from arachno-
phobic to normal during treatment. Five variables were used
to characterize each subject: BAT and SUDS with real spider,
BAT and SUDS with photo of a spider, and FSQ. The algo-
rithm was applied with these ﬁve variables gathered from the
25 arachnophobes at the beginning of treatment, and from
29 normal subjects recruited in the university. The k-means
algorithm was initially used to eliminate nonphobic subjects
from the group of volunteers, as explained in Section 2.1.
To calculate the percentages of patients that migrated from
arachnophobic tonormal along the diﬀerentstagesof the ex-
perimental procedure (see Table 2), the k-means algorithm
was fed with the scores of the participants in each one of the
stages (BAT spider, BAT photo, SUDS spider, SUDS photo,
and FSQ).
Duringthefourweeksoftreatment,41.7%ofindividuals
in the treatment group and 25% of the placebo group moved
over to the normal condition. When the placebo group was
treated, 50% fell in the normal group.
A more substantial improvement was evident in the
follow-up, six months after the conclusion of treatment:
91.7% of individuals in the treatment group and 90% of the
treated placebo group were classiﬁed as nonarachnophobes.
These results are discussed below.
4. DISCUSSION
In this section, the following topics will be discussed:
(1) the hypothetical assumptions taken into consideration
to elaborate the therapy;
(2) the neurocomputational background of the therapy;
(3) the inﬂuence of the BAT assessment test in the eﬃcacy
of SLAT;
(4) the delay of improvement in the FSQ;
(5) the therapeutical limitations of the procedure;
(6) suggestions for further studies.Laura Carmilo Granado et al. 7
Table 2:ImprovementoftheBAT,SUDS,andFSQscoresinTable 1 expressedinpercentages.Thepercentageofimprovementwascalculated
from Table 1 by dividing the measurement by the initial score. The last column exhibits the percentage of patients that migrated to the
condition of normal subjects, according to the k-means algorithm. According to this, in six months, 91.7% of the treatment-group subjects
became nonarachnophobes.
Real spider Spider photo FSQ Recovery (k-means) (%)
BAT SUD BAT SUD
Treatment
Improv. (%) 4 weeks 61.6 (19.4) 40.3 (22,9) 66.6 (31.2) 53 (51.7) 28.8 (20.5) 41.7
Improv. (%) 6 weeks 76.6 (27.9) 45.6 (46.1) 88.5 (17.1) 61.4 (53.6) 40 (27.1) 50
Improv. (%) (follow-up) 90.22 (25.74) 62.0 (2.7) 87.49 (17.52) 70.6 (37.4) 55.2 (23.4) 91.7
Placebo
Improv. (%) 4 weeks 28.8 (31.8) 5.9 (40.9) 47.3 (37.3) 21 (36.9) 15.7 (18.3) 25
Treatedplacebo
Improv. (%) 4 weeks 46.8 (31.5) 24.1 (28.4) 46.2 (37.2) 42.3 (42.1) 26.2 (19.1) 50
Improv. (%) 6 weeks 71.2 (38.7) 44.2 (35.1) 67 (40.7) 54 (39) 39.4 (25.8) 50
Improv. (%) (follow-up) 79.2 (33.6) 58.3 (31.1) 87.0 (21.4) 63.3 (40.6) 50.4 (26.7) 90
Treatmentandtreatedplacebo
Improv. (%) 4 weeks 55.2 (25.8) 33.3 (26.2) 57.7 (34.7) 48.3 (47.0) 27.7 (19.5) 43
Improv. (%) 6 weeks 74.3 (32.3) 45 (40.8) 79.1 (30.9) 58.1 (46.9) 39.7 (26.0) 50
Improv. (%) (follow-up) 85.2 (29.4) 60.3 (31.3) 87.3–18.9 67.3 (38.1) 53.1 (24.4) 91
4.1. Hypotheticalassumptionsfor
elaboratingtheSLAT
Two hypothetical assumptions that are consistent with neu-
rological ﬁndings served to delineate the methodology of
SLAT. The results of the therapy, however, are not intended
toassessthevalidityofthesepreliminaryassumptions,which
would require much further conﬁrmation.
(a) The ﬁrst assumption is that some connections from
thalamus to amygdala are abnormally potentiated in pho-
bic patients, possibly because of a process in which a con-
ditioned stimulus (CS), the phobic object, is associated with
an unconditioned stimulus (US) such as a loud sound or
an acute pain. The possibility of plastic changes taking place
in the thalamo-amygdala pathway is supported by the work
of Doy´ ere et al. [15], in which they were able to induce
long-term potentiation (LTP) in thalamic and cortical in-
puts to the amygdala in freely moving rats, demonstrating
that LTP in thalamic inputs is much more persistent and
long-lasting than LTP in cortical inputs. LeDoux, Schafe et
al. (Apergis-Schoute et al. [22]) have further shown that in-
tralaminar thalamic neurons contribute to presynaptic plas-
ticity in the thalamo-amigdaloid pathway during fear condi-
tioning. Thalamic intralaminar neurons are also described as
a locus of functional CS-US convergence for fear condition-
ing to acoustic stimuli (Cruikshank et al. [23]). The possibil-
ity of altering these circuits by means of either habituation
to the spider or by cognitive-behavioral therapy is also men-
tioned, for example, by Veltman et al. [24] and Paquette et al.
[25].
Regardingthedegreetowhichplasticchangeswouldtake
place in the thalamo-amygdaloid pathway, it is worth men-
tioningthatpostsynapticvoltagevalueiscriticaltodetermin-
ing whether a synapse is reinforced or depressed (Figure 3).
According to Figure 3, postsynaptic depolarization deter-
mines the potentiation or depression of a given synapse.
If the value of postsynaptic depolarization is greater than
a threshold, called the LTP threshold, active synapses are
potentiated (i.e., increment their synaptic connectivity or
synaptic weight); below this threshold they are depressed
(Artola and Singer [26]; Bear et al. [27]) (these synapses
experiment a decrement of their synaptic connectivity or
synaptic weight). If the postsynaptic depolarization is very
low, synaptic depression is small or null.
WeconjecturedthattheeﬀectivenessofSLATdependson
activatingneuronsthatprojectfromthalamustoamygdalain
suchawaythattheyareinsidethedepressioninterval.Unfor-
tunately,depressionintervalsvaryforeachsynapseaccording
to a synaptic property called metaplasticity. The same post-
synaptic activity may produce potentiation in one synapse
anddepressioninanotherwhileleavingathirdunaltered.We
were also unable to directly evaluate the postsynaptic activity
that a given SLAT ﬁgure produced in these neurons.
Despite all these diﬃculties, we conjectured that the
fear reaction produced by SLAT ﬁgures was correlated
to the postsynaptic activity in neurons in the thalamo-
amygdaloidpathway.Toavoidpotentiationandfavordepres-
sion, fearful images were omitted from the presentation (see
Section 2.3.2). The duration of the remaining images were
adjusted so that comfortable images were exhibited during
a longer time and less comfortable images during a shorter
interval.
(b) The second hypothetical assumption that served to
delineate SLAT is related to the nature of the archetypal in-
formation that, according to LeDoux, is relayed from the
thalamus to the amygdala. Morris et al. [28] found that the
amygdala appears to sum, in a nonlinear manner, individual8 Neural Plasticity
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Figure 2: Time course of the BAT and SUDS means with a real spider, (a) and (b), and with a spider photo, (c) and (d), for placebo and
treatment groups. Vertical segments indicate standard error.
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Figure 3:Variationofsynapticeﬃciency(synapticweight)interms
of postsynaptic activity. For levels of postsynaptic activity above the
LTP threshold, synaptic potentiation (positive variation of synaptic
weight) takes place. Between the LTD and LTP thresholds, synaptic
depression (a negative variation of synaptic weight) occurs. Below
the LTD threshold there is no variation of synaptic eﬃciency.
responses to speciﬁc facial features. A two-stage theory for
facial perception of emotions was proposed by De Bonis et
al. [29] and tested by Morris et al. [28], who concluded that
“the perception of emotional expressions depends on an ini-
tialprocessingofindividualfacialfeaturesfollowedbyanon-
linear association of the diﬀerent components.” According to
Weinbergerandcollaborators(LennartandWeinberger[30];
Edeline and Weinberger [31]), the thalamus is able to recog-
nize features, augmenting its response to a speciﬁc feature
that was previously paired to a US.
4.2. Neurocomputationalfoundations
Neurocomputational models (Pel´ aez [32, 33]) are consistent
with the two-stage theory, conjecturing that the ﬁrst stage
of the process, the preliminary processing of individual fea-
tures, is performed in the thalamus. According to these mod-
els, in the thalamus each sensory pattern is represented as a
vector with components in a coordinate frame in which each
axis corresponds to a speciﬁc feature of the pattern. Each one
of these axes/features corresponds to the output of a tha-
lamic reticular neuron. The output of these reticular neu-
rons (Crabtree and Isaac [34]) is nonlinearly summed by in-
tralaminar neurons (see Figure 4) and if this sum exceeds a
threshold, the result is relayed to the amygdala. According to
the computational model, the set of axes/features created by
the ﬁring of reticular neurons in the thalamus, constitute a
code that identiﬁes, in a rough way, each input pattern. This
code would correspond to the rough, almost archetypal de-
scription of the aversive stimuli, that, according to LeDoux
and colleagues (LeDoux [14]; Doy´ ere et al. [15]), is passed
from the thalamus to the amygdala.
According to the ﬁrst assumption, a way of depress-
ing thalamo-amygdaloid synapses would be by avoiding
high post-synaptic potentials in thalamo-amygdaloid neu-
rons by means of reducing the intensity of phobic stimuli
(Figure 3). A possible way of reducing this intensity wouldLaura Carmilo Granado et al. 9
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Figure 4: Hypothetical arrangement of thalamus and amygdala
connections, used in the computational model that inspired the
therapyheredescribed(SLAT).R:thalamicreticularneurons;I:tha-
lamic intralaminar neurons; L: lateral nucleus of the amygdale; C:
central nucleus of the amygdala. Due to a competitive process per-
formed between reticular neurons in the model, each one of them
responds to a speciﬁc feature of a sensory pattern (Pel´ aez [32, 33]).
Asimilarcompetitiveprocesstakesplacebetweenintralaminarneu-
rons, each one responding to a speciﬁc combination of features.
Therefore, a certain number of features, that is, reticular neurons,
are necessary for ﬁring a speciﬁc intralaminar neuron. When this
number is low, a low postsynaptic activity in intralaminar neuron
favors synaptic depression, according to Figure 3, thereby reduc-
ing the possibility of future intralaminar neuron ﬁring. In this way,
the thalamic-amygdala pathway is depressed in the computational
model.
be by masking or obscuring the phobic object. However, a
masked or obscured phobic object is still intense enough to
ﬁre the amygdala (Whalen et al. [35]) and aversive for pa-
tients.
Instead of reducing the duration or intensity of spider
images, we propose to reduce the number of arachnoid fea-
turespresentineachimage.Accordingtothesecondassump-
tion, when the number of arachniform features in the in-
put pattern is reduced, the activation of intralaminar neu-
rons (computing the sum of these features) is also reduced.
This lower activation of intralaminar neurons contributes
to reduce the activation of the neurons in the thalamo-
amigdaloid axis, so that their synapses would undergo de-
pression instead of potentiation. Therefore, when, instead of
the spider code, a code with a smaller repertoire of arachni-
form features is relayed, neurons in the thalamo-amigdaloid
pathwayarehypotheticallylessactivated,theirsynapsesmore
prompted to undergo depression rather than potentiation.
4.3. InﬂuenceoftheBATassessmenttest
intheefﬁcacyoftheSLAT
Both treatment and placebo groups underwent BAT and
SUDS assessment test weekly. Volunteers were told to ap-
proach the spider without forcing themselves. The purpose
of this instruction was to adhere, during the BAT and SUDS
tests, to the principles that inspired the therapy, that is, to
avoid any stimuli that could contribute to enhance thalamo-
amygdala connectivity.
It could be argued that the BAT assessment test could, by
itself, have a therapeutical eﬀect over arachnophobia. This
eﬀect might be thought to be responsible for the improve-
ment observed in the placebo group. However, as shown in
Section 3.2, improvement of patients in the treatment group
was signiﬁcantly better than that of patients in the placebo
group.
4.4. ThedelayofimprovementintheFSQ
Manypatientsreportedthattheydidnotrealizethattheyhad
lost their fear of spiders until they were confronted to a real
spider during their daily life. They had the strange sensation
of not reacting with fear when, for the ﬁrst time after treat-
ment, they saw a real spider. Since during daily life, a real
confrontation with a spider is an unpredictable event, the re-
alizationofhavinglostthefearvariesfromindividualtoindi-
vidual. The BAT assessment test, independently of its possi-
ble placebo eﬀect, could contribute to accelerate this process
of realization.
Related to this, we observed that the improvement in the
FSQ was delayed in comparison to the improvement in the
automatic responses measured by the BAT and SUDS. This
is consistent with the reasonable supposition that patients
did not realize that they had lost their fear until they actu-
ally confronted a real spider during their daily life situations.
Depending on the frequency with which they actually con-
frontedaspiderintheirdailylives,therealizationofrecovery
took a shorter or longer time in the diﬀerent patients. This
fact was reﬂected in the follow-up study that was carried out
six months after the conclusion of the treatment.
4.5. Therapeuticallimitations
Although the 25 subjects that took part in the experiment
came from a very large sample of 160 arachnophobic vol-
unteers, there were no volunteers above the age of 46. Taking
intoaccountthatneuralplasticitydependsonage(Burkeand
Barnes[36])andthatourexperimentswerenotabletoassess
thetherapeuticeﬀectofSLATinelderlypeople,wesuggestto
applytheSLATtopatientsbelowtheageof46,untilperform-
ing an assessment with older volunteers in the future.
4.6. Suggestionsforfurtherstudies
The 160 arachnophobic patients that contacted us were clas-
siﬁed in terms of their degree of arachnophobia. Among the
six with the highest scores, three of them suﬀered thyroid
hormone impairment. We wondered whether this coinci-
dence might be a possible psycho-somatic eﬀect produced
in the long run by arachnophobia. A similar case of thyroid
hormone alteration was found in the literature (Friedman et
al. [37]) among women with posttraumatic stress disorders.
These considerations motivate a study to assess the relation-
ship between thyroid hormone alteration and phobias.
According to our theoretical assumptions, the SLAT acts
at subcortical levels. Neuroimaging studies could help to
evaluate this assumption by comparing the brain activa-
tion before and after the SLAT. A similar comparison was
done by Paquette et al. [25], in which arachnophobic pa-
tients were treated with cognitive behavioral therapy. This
study concluded that the dorsolateral prefrontal cortex and10 Neural Plasticity
the parahippocampal gyrus diminished their activation sig-
niﬁcantly after treatment with cognitive behavioral therapy.
InthecaseoftheSLAT,weexpectthatreductionofactivityin
the dorsolateral prefrontal cortex and the parahippocampal
gyrus will be preceded by reduced activity of amygdala and
superior colliculus. This sequence would be consistent with
the fact that during the SLAT, improvement in the BAT test
(measuring automatic responses) proceeded the improve-
ment in the FSQ tests (measuring cognitive variables related
to fear of spiders).
5. CONCLUSION
A novel technique for treating spider phobia, that does not
require any use of spiders, was described and tested. In the
SLAT, here described, each patient is given a personalized
presentation in a compact disk, containing a set of images
that, although not containing spiders, present subsets of spi-
der characteristics. The degree to which each image evokes
a spider in diﬀerent patients is diﬀerent. The most evoca-
tive images are excluded from the personalized presentation
whereas the less evocative images are presented to the pa-
tient during a longer interval (see Section 2.3.2). Regarding
the subtlety of the images, two treatment group patients de-
clared that they thought they were in the placebo group be-
cause their presentation caused no discomfort at all.
To compare the evolution of the placebo and treatment
groups, a four-week experiment was designed. Treatment
and placebo groups went through their corresponding pre-
sentation twice a day and came once a week to the university
to apply the BAT and SUDS tests. To carry out these tests,
instead of encouraging the subjects to approach as much as
possible to a spider, they were told to approach the spider,
but without forcing themselves. They could also refuse to do
the test, which was the case of three treatment subjects in
their initial evaluation (see Section 3.1). This kind of sugges-
tion respects the desire of the subjects of not confronting the
spider in any way, and is coherent with the main philoso-
phy of the procedure, according to which the subtler the bet-
ter. The improvement in every measure of phobia was higher
for the treatment group than in the placebo group (see Ta-
bles 1 and 2). Moreover, the repeated measures multivariate
ANOVA showed that the patients’ improvement was not due
to a placebo eﬀect (group × time interaction: F(1,23) = 7.98,
P = .0096).
In the follow-up study performed after six months,
91.7% of the patients in the treatment group were classiﬁed
as nonarachnophobes by the k-means algorithm, six patients
of this group opened the lid of the tarantula cage, and, of
these, three touched the tarantula.
The therapy proposed here was aimed at subconscious,
automatic responses, while behavioral or psychoanalytic
therapies emphasize the rational control of fear reactions.
AccordingtoLeDoux[38],thealterationoffearbehaviorcan
be produced by the cortical control of fear reactions without
the actual deletion of what LeDoux calls “fear memories,”
that once established become relatively permanent. These
“fear memories” were intentionally the targets of the therapy
proposed in this paper.
SLAT is particularly appropriate for, but not exclusive to,
those patients who, because of the severity of their arachno-
phobia or whatever other reason, are unwilling to undergo
therapies that involve any real, imagined or virtual spider.
The theoretical basis of the therapeutic strategy was aiming
toproduceplasticchangesinthethalamo-amygdaloidcircuit
responsible for the subconscious, automatic reactions trig-
gered when the subject sees a spider. The therapy might have
been eﬀective for other, fortuitous, reasons, but the consis-
tency with the theoretical basis that motivated it (Sections
4.1 and 4.2) is very encouraging, both from a practical point
of view, providing an additional strategy to deal with certain
phobias,andfromatheoreticalpointofview,motivatingfur-
ther studies to test these ideas.
ABBREVIATIONS
ANOVA: Analysis of variance
BAT: Behavioral avoidance test
CS: Conditioned stimulus
DSM IV: Diagnostic and Statistical Manual of Mental
Disorderes (4th ed.)
FSQ: Fear of spider questionaire
LTD: Long-term depression
LTP: Long-term potentiation
SCID: Structured Clinical Interview for DSM IV
SLAT: Spiderless arachnophobia therapy
SUDS: Subjective units of disconfort scale
US: Unconditioned stimulus
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